Form 4 Tracker
Axsome Therapeutics, Inc.
AXSM

33 insider filings · Latest: Jul 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 6, 2026Jan 6 9:58 PMHerriot Tabuteau
Proposed Sale
29,450$171.88$5.1M

View →

Jan 5, 2026Jan 5 10:18 PMHerriot Tabuteau
Proposed Sale
78,703$171.49$13.5M

View →

Dec 31, 2025Dec 31 9:00 PMSaad Mark E
Proposed Sale
37,577$165.18$6.2M

View →

Dec 4, 2025Dec 4 10:11 PMHerriot Tabuteau
Proposed Sale
10,558$148.04$1.6M

View →

Dec 3, 2025Dec 3 10:58 PMHerriot Tabuteau
Proposed Sale
20,163$147.81$3.0M

View →

Dec 2, 2025Dec 2 10:14 PMHerriot Tabuteau
Proposed Sale
49,252$142.09$7.0M

View →

Nov 5, 2025Nov 6 12:19 AMHerriot Tabuteau
Proposed Sale
21,775$135.69$3.0M

View →

Nov 4, 2025Nov 4 10:47 PMHerriot Tabuteau
Proposed Sale
50,459$134.93$6.8M

View →

Nov 3, 2025Nov 3 10:56 PMHerriot Tabuteau
Proposed Sale
91,705$135.75$12.4M

View →

Oct 8, 2025Oct 8 8:54 PMHerriot Tabuteau
Proposed Sale
12,774$118.71$1.5M

View →

Oct 7, 2025Oct 7 8:43 PMHerriot Tabuteau
Proposed Sale
13,390$118.64$1.6M

View →

Oct 6, 2025Oct 6 8:47 PMHerriot Tabuteau
Proposed Sale
19,220$119.94$2.3M

View →

Sep 22, 2025Sep 22 8:13 PMJacobson Mark L.
Proposed Sale
10,000$115.96$1.2M

View →

Sep 16, 2025Sep 16 9:39 PMJacobson Mark L.
Proposed Sale
45,783$114.48$5.2M

View →

Sep 16, 2025Sep 16 8:47 PMHerriot Tabuteau
Proposed Sale
19,719$114.10$2.2M

View →

Sep 15, 2025Sep 15 10:35 PMHerriot Tabuteau
Proposed Sale
15,254$116.78$1.8M

View →

Sep 12, 2025Sep 12 11:19 PMHerriot Tabuteau
Proposed Sale
27,907$118.42$3.3M

View →

Sep 5, 2025Sep 5 9:08 PMSaad Mark E
Proposed Sale
9,127$125.07$1.1M

View →

Sep 2, 2025Sep 2 8:01 PMJEFFS ROGER
Proposed Sale
13,464$123.68$1.7M

View →

Aug 29, 2025Aug 29 8:02 PMJEFFS ROGER
Proposed Sale
20,000$121.27$2.4M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 26, 2026Feb 28 12:10 AMNick PizzieChief Financial Officer
Grant/Award
18,57018,570(D)

View →

Feb 26, 2026Feb 28 12:10 AMHunter R. MurdockGeneral Counsel
Grant/Award
16,38516,385(D)

View →

Feb 26, 2026Feb 28 12:10 AMAri MaizelChief Commercial Officer
Grant/Award
16,38516,385(D)

View →

Feb 26, 2026Feb 28 12:10 AMMark L. JacobsonChief Operating Officer
Grant/Award
19,66319,663(D)

View →

Feb 26, 2026Feb 28 12:00 AMMark L. JacobsonChief Operating Officer
Option Exercise
35,378$2.850(D)

View →

Feb 23, 2026Feb 26 12:00 AMMark ColemanDirector
Option Exercise
6,250$4.957,721(D)

View →

Feb 20, 2026Feb 24 12:23 AMMark ColemanDirector
Option Exercise
12,485$4.9513,971(D)

View →

Feb 10, 2026Feb 11 12:11 AMMark ColemanDirector
Option Exercise
5,193$8.020(D)

View →

Feb 2, 2026Feb 2 11:30 PMTABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner
Option Exercise
32,410$185.600(D)

View →

Jan 22, 2026Jan 24 12:00 AMNick PizzieChief Financial Officer
Option Exercise
12,000$3.50105,000(D)

View →

Jan 21, 2026Jan 24 12:00 AMAri MaizelChief Commercial Officer
Option Exercise
7,500$70.7331,210(D)

View →

← Previous

Page 2 of 2